snk01
snk01: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NKGen Biotech, Inc. (NKGN) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase I/IIa, Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Moderate Alzheimer's Disease
Frequently asked questions
Who is developing snk01?
snk01 is being developed by NKGen Biotech, Inc..
How many clinical trials involve snk01?
BioSniper tracks 1 clinical trial involving snk01.
Get deeper analysis on snk01
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis